Literature DB >> 25622812

Assessing Amide Proton Transfer (APT) MRI Contrast Origins in 9 L Gliosarcoma in the Rat Brain Using Proteomic Analysis.

Kun Yan1, Zongming Fu, Chen Yang, Kai Zhang, Shanshan Jiang, Dong-Hoon Lee, Hye-Young Heo, Yi Zhang, Robert N Cole, Jennifer E Van Eyk, Jinyuan Zhou.   

Abstract

PURPOSE: To investigate the biochemical origin of the amide photon transfer (APT)-weighted hyperintensity in brain tumors. PROCEDURES: Seven 9 L gliosarcoma-bearing rats were imaged at 4.7 T. Tumor and normal brain tissue samples of equal volumes were prepared with a coronal rat brain matrix and a tissue biopsy punch. The total tissue protein and the cytosolic subproteome were extracted from both samples. Protein samples were analyzed using two-dimensional gel electrophoresis, and the proteins with significant abundance changes were identified by mass spectrometry.
RESULTS: There was a significant increase in the cytosolic protein concentration in the tumor, compared to normal brain regions, but the total protein concentrations were comparable. The protein profiles of the tumor and normal brain tissue differed significantly. Six cytosolic proteins, four endoplasmic reticulum proteins, and five secreted proteins were considerably upregulated in the tumor.
CONCLUSIONS: Our experiments confirmed an increase in the cytosolic protein concentration in tumors and identified several key proteins that may cause APT-weighted hyperintensity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25622812      PMCID: PMC4496258          DOI: 10.1007/s11307-015-0828-6

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  44 in total

1.  Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues.

Authors:  M Stoeckli; P Chaurand; D E Hallahan; R M Caprioli
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

Review 2.  Proteomics in biomarker discovery and drug development.

Authors:  Qing-Yu He; Jen-Fu Chiu
Journal:  J Cell Biochem       Date:  2003-08-01       Impact factor: 4.429

3.  Removal of discrete fresh regions of the rat brain.

Authors:  D M Jacobowitz
Journal:  Brain Res       Date:  1974-11-08       Impact factor: 3.252

4.  Isolated removal of hypothalamic or other brain nuclei of the rat.

Authors:  M Palkovits
Journal:  Brain Res       Date:  1973-09-14       Impact factor: 3.252

5.  Proteomic studies on low- and high-grade human brain astrocytomas.

Authors:  Federico Odreman; Marco Vindigni; Marlen Lujardo Gonzales; Benedetta Niccolini; Giovanni Candiano; Bruno Zanotti; Miran Skrap; Stefano Pizzolitto; Giorgio Stanta; Alessandro Vindigni
Journal:  J Proteome Res       Date:  2005 May-Jun       Impact factor: 4.466

6.  Growth properties of SF188/V+ human glioma in rats in vivo observed by magnetic resonance imaging.

Authors:  Rachel Grossman; Betty Tyler; Henry Brem; Charles G Eberhart; Silun Wang; De-Xue Fu; Zhibo Wen; Jinyuan Zhou
Journal:  J Neurooncol       Date:  2012-09-27       Impact factor: 4.130

7.  Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response.

Authors:  Adrienne N Dula; Lori R Arlinghaus; Richard D Dortch; Blake E Dewey; Jennifer G Whisenant; Gregory D Ayers; Thomas E Yankeelov; Seth A Smith
Journal:  Magn Reson Med       Date:  2012-08-20       Impact factor: 4.668

8.  Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma.

Authors:  Susan M Chang; Sarah Nelson; Scott Vandenberg; Soonmee Cha; Michael Prados; Nicholas Butowski; Michael McDermott; Andrew T Parsa; Manish Aghi; Jennifer Clarke; Mitchel Berger
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

9.  Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semi-solid magnetization transfer reference (EMR) signals: Application to a rat glioma model at 4.7 Tesla.

Authors:  Hye-Young Heo; Yi Zhang; Dong-Hoon Lee; Xiaohua Hong; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2015-03-05       Impact factor: 4.668

10.  APT-weighted and NOE-weighted image contrasts in glioma with different RF saturation powers based on magnetization transfer ratio asymmetry analyses.

Authors:  Jinyuan Zhou; Xiaohua Hong; Xuna Zhao; Jia-Hong Gao; Jing Yuan
Journal:  Magn Reson Med       Date:  2013-05-09       Impact factor: 4.668

View more
  41 in total

1.  Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.

Authors:  Shanshan Jiang; Tianyu Zou; Charles G Eberhart; Maria A V Villalobos; Hye-Young Heo; Yi Zhang; Yu Wang; Xianlong Wang; Hao Yu; Yongxing Du; Peter C M van Zijl; Zhibo Wen; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2017-07-16       Impact factor: 4.668

Review 2.  Amide proton transfer imaging of tumors: theory, clinical applications, pitfalls, and future directions.

Authors:  Kiyohisa Kamimura; Masanori Nakajo; Tomohide Yoneyama; Koji Takumi; Yuichi Kumagae; Yoshihiko Fukukura; Takashi Yoshiura
Journal:  Jpn J Radiol       Date:  2018-10-19       Impact factor: 2.374

3.  Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semisolid magnetization transfer reference (EMR) signals: II. Comparison of three EMR models and application to human brain glioma at 3 Tesla.

Authors:  Hye-Young Heo; Yi Zhang; Shanshan Jiang; Dong-Hoon Lee; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2015-05-28       Impact factor: 4.668

4.  Tumor pH and Protein Concentration Contribute to the Signal of Amide Proton Transfer Magnetic Resonance Imaging.

Authors:  Kevin J Ray; Manon A Simard; James R Larkin; James Coates; Paul Kinchesh; Sean C Smart; Geoff S Higgins; Michael A Chappell; Nicola R Sibson
Journal:  Cancer Res       Date:  2019-01-24       Impact factor: 12.701

5.  Prospective acceleration of parallel RF transmission-based 3D chemical exchange saturation transfer imaging with compressed sensing.

Authors:  Hye-Young Heo; Xiang Xu; Shanshan Jiang; Yansong Zhao; Jochen Keupp; Kristin J Redmond; John Laterra; Peter C M van Zijl; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2019-06-17       Impact factor: 4.668

6.  Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.

Authors:  Shanshan Jiang; Qihong Rui; Yu Wang; Hye-Young Heo; Tianyu Zou; Hao Yu; Yi Zhang; Xianlong Wang; Yongxing Du; Xinrui Wen; Fangyao Chen; Jihong Wang; Charles G Eberhart; Jinyuan Zhou; Zhibo Wen
Journal:  Eur Radiol       Date:  2017-12-12       Impact factor: 5.315

7.  Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas.

Authors:  Bo Ma; Jaishri O Blakeley; Xiaohua Hong; Hongyan Zhang; Shanshan Jiang; Lindsay Blair; Yi Zhang; Hye-Young Heo; Mingzhi Zhang; Peter C M van Zijl; Jinyuan Zhou
Journal:  J Magn Reson Imaging       Date:  2016-01-20       Impact factor: 4.813

8.  Direct saturation-corrected chemical exchange saturation transfer MRI of glioma: Simplified decoupling of amide proton transfer and nuclear overhauser effect contrasts.

Authors:  Iris Yuwen Zhou; Enfeng Wang; Jerry S Cheung; Dongshuang Lu; Yang Ji; Xiaoan Zhang; Giulia Fulci; Phillip Zhe Sun
Journal:  Magn Reson Med       Date:  2017-10-13       Impact factor: 4.668

9.  Insight into the quantitative metrics of chemical exchange saturation transfer (CEST) imaging.

Authors:  Hye-Young Heo; Dong-Hoon Lee; Yi Zhang; Xuna Zhao; Shanshan Jiang; Min Chen; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2016-05-12       Impact factor: 4.668

10.  Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI.

Authors:  Tianyu Zou; Hao Yu; Chunxiu Jiang; Xianlong Wang; Shanshan Jiang; Qihong Rui; Yingjie Mei; Jinyuan Zhou; Zhibo Wen
Journal:  NMR Biomed       Date:  2017-11-03       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.